Monte Rosa Therapeutics, Inc. (GLUE)
17.40
+0.23
(+1.34%)
USD |
NASDAQ |
Apr 02, 10:10
Monte Rosa Therapeutics Profit Margin (Quarterly) : -1.66K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 20.83% |
| Agenus, Inc. | -31.03% |
| Amicus Therapeutics, Inc. | 0.91% |
| CorMedix, Inc. | 10.90% |
| BioRestorative Therapies, Inc. | -16.37K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.51% |
| Return on Assets | -9.20% |
| Return on Invested Capital | -13.32% |
| Gross Profit Margin (Quarterly) | 24.92% |
| Operating Margin (Quarterly) | -1.79K% |
| Return on Net Operating Assets | -69.80% |